Clinical Interview Highlights of 2014

It has been a busy year for SelectScience. We have carried out exclusive interviews in some of the most advanced clinical laboratories in the world. In this article, we highlight just some of these interesting interviews. We look forward to bringing you even more exclusive reports in 2015.

1. Analyzing Footballers with Mass Spec: Exclusive WADA Anti-Doping Interview

SelectScience went behind the scenes at the WADA-accredited Laboratoire Suisse d’Analyse du Dopage (LAD) in Switzerland, during the 2014 FIFA World Cup. During our visit, we learned how state-of-the-art mass spectrometry is being used to detect the smallest amounts of forbidden substances in samples. The selectivity and sensitivity of LC-MS is essential to LAD in the ongoing fight against doping in sport.
Watch WADA Anti-Doping Video

2. Could Point-of-Care Testing Stop Ebola Outbreak?

In this exclusive interview, Matt Boisen, the Director of In-vitro Diagnostic Development for the Viral Hemorrhagic Fever Consortium, and Program Director of Infectious Disease and Emerging Technologies at Corgenix Medical Corp, discusses a recent grant awarded to Corgenix to advance the development of an Ebola rapid diagnostic test kit.
Read Ebola Interview

3. The Evolution of Rapid POC Tests for Infectious Disease Diagnostics: An Exclusive SelectScience Interview

ArcDia’s R&D Director, Janne O. Koskinen, discusses the increasing trend towards the rapid point-of-care (POC) diagnostics market and how the evolution of bacterial rapid diagnostics might continue in the future.
Read Infectious Diseases Interview

4. Innovative Cloud Computing Solutions for the Clinical Laboratory

In this interview, Troy Galloway, Director of North America Marketing, discusses the strategic partnership between Beckman Coulter Diagnostics and hc1.com® the Healthcare Relationship Cloud^TM company. This is an interesting alliance that promises to deliver innovative technology to laboratories, allowing them to turn large amounts of clinical data into actionable insights.
Watch Cloud Computing Interview

5. New Weaponry Available in Antimicrobial Resistance Fight: Don’t Send Us Back to the Dark Ages!

The recent European Antibiotics Awareness Day raised international awareness of antimicrobial resistance in Australia, Canada and the USA. Randox Laboratories announced its support for the call for patients and prescribers to ‘resist and desist’ antibiotic use in an effort to curb the spread of antimicrobial resistance. In this interview, Dr Peter FitzGerald, Managing Director at Randox Laboratories, discusses the rising use of antibiotics and a new multiplex respiratory assay that could help physicians make improvements to their antibiotic prescriptions.
Read Antibiotic Resistance Artice – Part 1
Read Antibiotic Resistance Artice – Part 2